Skip to content

Clinical trials

Completed Idiopathic Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Completed Country / region: United States Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20035
20041
20054
20063
20074
20085
20094
20105
20116
20124
201310
20142
20158
20169
20176
20186
20198
20208
20214
20226
20239
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim13
Bristol-Myers Squibb5
Genentech, Inc.5
Hoffmann-La Roche5
Duke University4
National Heart, Lung, and Blood Institute (NHLBI)4
National Jewish Health4
University of Alabama at Birmingham4
University of Michigan4
Actelion3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis132
Pulmonary Fibrosis24
Lung Diseases, Interstitial21
Fibrosis8
Lung Diseases8
Hypertension, Pulmonary5
Pulmonary Arterial Hypertension5
Idiopathic Interstitial Pneumonias4
Respiratory Tract Diseases3
Connective Tissue Diseases2

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.